UNCY — Unicycive Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareSmall Cap
U.S. RESEARCH ROUNDUP-Doordash, Phillips 66, United Therapeutics
U.S. STOCKS ON THE MOVE-Lockheed Martin, ManpowerGroup, Parker-Hannifin
U.S. STOCKS ON THE MOVE-Lockheed Martin, ManpowerGroup, Parker-Hannifin,
U.S. STOCKS ON THE MOVE-Blackstone, Summit, Lockheed Martin
Brief: Unicycive Therapeutics Announces FDA Acceptance Of Oxylanthanum Carbonate (OLC) New Drug Application (NDA) Resubmission
Unicycive rises as FDA accepts resubmitted filing for kidney drug
Brief: Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Brief: Unicycive Therapeutics Increases ATM Offering To $100 Million - SEC Filing
Unicycive Therapeutics Q3 net loss widens to $6 mln
Brief: Unicycive Therapeutics Says Co Became Aware Of Securities Class Action Lawsuit
Brief: Unicycive Therapeutics Granted New U.S. Patent For Uni-494 To Treat Chronic Kidney Disease
U.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unicycive tumbles as FDA rejects kidney disease drug over manufacturing issues
Brief: Unicycive Therapeutics - Crl Cites Deficiencies At Third-Party Manufacturing Vendor Unrelated To Olc
Brief: Unicycive Therapeutics Announces Reverse Stock Split
U.S. STOCKS ON THE MOVE-Citigroup, Boeing, Calavo Growers
U.S. STOCKS ON THE MOVE-Academy Sports, energy stocks, FirstEnergy
U.S. STOCKS ON THE MOVE-United Natural Foods, Insmed, MacroGenics